Abstract:Objective To compare the clinical efficacy and safety of two chemotherapy regimens for concurrent chemoradiotherapy in patients with stage Ⅰ b2 to Ⅳ a squamous cell carcinoma of the uterine cervix.Methods Between November 2007 and November 2011,146 patients with stage Ⅰ b2 to Ⅳ a squamous cell carcinoma of the uterine cervix who received concurrent chemoradiotherapy in Peking University Cancer Hospital were analyzed.All cases were divided into two groups according to the different chemotherapy regimens during radiation therapy,the group receiving radiotherapy concomitant with weekly cisplatin or nedaplatin alone (platinum alone group,n =59),the group receiving radiotherapy concomitant with cisplatin plus fluorouracil or nedaplatin plus tegafur every 3 weeks (combined group,n =87).There were no statistical difference in the clinical and pathological characteristics between the two groups.Results Patients were evaluated by pelvic examination and pelvic MRI after chemoradiotherapy for 3 months according to WHO criteria.The response rate were respectively 97％ (57/59) and 93％ (81/87) in platinum alone group and combined group,in which there was no significant difference (P =0.249).The five-year overall survival and the five-year progression-free survival of platinum alone group and combined group were respectively 61.2％ versus 69.5％ (P ＞ 0.05) and 43.3％ versus 24.4％ (P ＞ 0.05).There were also no statistically significant differences between platinum alone group and combined group in the five-year local recurrence rate and five-year distant metastasis (11.8％ versus 9.8％,29.4％ versus 38.7％ ; all P ＞ 0.05).Acute gastrointestinal toxicities (nausea and vomiting) in combined group were exactly higher than that in the other group [78％ (68/87) versus 51％ (30/59),P ＜0.01].Moreover,anaemia was slightly more common in combined group [53％ (46/87) versus 25％ (15/59),P =0.019].However,the occurrence rate of the acute or late proctitis and cystitis did not reveal difference between two groups (P ＞ 0.05).Conclusions Both concurrent chemoradiotherapy regimens had similar efficacy on cervical cancer patients with stage Ⅰ b2 to Ⅳa.But the toxicity was lower in patients with weekly platinum than those with platinum-based combined regimens during radiation therapy.

The evaluation of short-term efficacy of docetaxel combined with carboplatin concurrent radiotherapy and chemotherapy in the treatment of advanced cervical cancer

Efficacy of Docetaxel Combined with Cisplatin in the Treatment of Advanced Thymic Carcinoma

Clinical observation of docetaxel combined with cisplatin in treatment of advanced esophageal cancer with synchronous radiotherapy

Docetaxel combined with intraperitoneal hyperthermic perfusion chemotherapy and hyperthermia to cure advanced ovarian cancer

Radio-frequency heating therapy combined with radiotherapy in the treatment of cervical metastatic carcinomas

Efficacy and Safety of Image-Guided Intensity-Modulated Radiation Therapy and Volumetric Modulated Arc Therapy Combined with Paclitaxel Liposomes and Cisplatin for Locally Advanced Stage IIB–IIIB Cervical Cancer: A Retrospective Study at a Single Center

Comparison of two platinum-containing chemotherapy regimens in the treatment of advanced cervical cancer with concurrent chemoradiotherapy

Postoperative intensity - modulated radiotherapy synchronous chemotherapy for cervical cancer

Clinical Observation on Docetaxel Combined with Cisplatin and Fluorouracil in Treatment of Patients with Advanced Gastric Cancer: a Report of 48 Cases

Experimental and Clinical Study of Concomitant Radiation Therapy and Chemotherapy for Cervical Carcinoma

Evaluating the clinical efficacy and safety of concurrent chemoradiotherapy with cisplatin and nab-paclitaxel in postoperative early-stage cervical cancer

Clinical observation of docetaxel combined with cisplatin and 5-fluorouracil in the treatment of advanced gastric cancer

Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ⅰb2 to Ⅳ a squamous cell carcinoma of the uterine cervix

Comparison of the efficacy among multiple chemotherapeutic interventions combined with radiation therapy for patients with cervix cancer after surgery: A network meta-analysis

An Analysis on Weekly Docetaxel Combined with Cisplatin for 46 Cases with Non-Small Cell Lung Cancer

Effective Treatment of Esophageal Carcinomas Using Intensity-Modulated Radiotherapy in Combination with Nedaplatin and Docetaxel

Efficiency of Deep Hyperthermia Combined with Concurrent Chemo-Radiotherapy in the Advanced Cervical Cancer

Clinical Efficacy of Neoadjuvant Chemotherapy Combined with Trastuzumab for HER-2 Positive Breast Cancer

The Efficacy of Pemetrexed Combined Cis-platinum Chemotherapy for Patients with Advanced Non Small Cell Lung Cancer and the Effect on Serum Tumor Markers

Clinical Observation on Metastatic or Recurrent Esophageal Cancer Treated with Combination of Docetaxel and Radiotherapy

Short-term Curative Effects of Docetaxel Combined with Capecitabine in Neoadjuvant Chemotherapy of Triple-negative Breast Cancer and Non Triple-negative Brest Cancer